C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease

Código QR

C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease

Abstract This study assesses whether C-terminal fragments (CTF) of the amyloid precursor protein (APP) are present in cerebrospinal fluid (CSF) and their potential as biomarkers for Alzheimer’s disease (AD). Immunoprecipitation and simultaneous assay by Western blotting using multiplex fluorescence...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	María-Salud García-Ayllón, Inmaculada Lopez-Font, Claudia P. Boix, Juan Fortea, Raquel Sánchez-Valle, Alberto Lleó, José-Luis Molinuevo, Henrik Zetterberg, Kaj Blennow, Javier Sáez-Valero
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2017
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/cb69aef9120f49b8950c4c51cc31dc80
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Extracellular fluid, cerebrospinal fluid and plasma biomarkers of axonal and neuronal injury following intracerebral hemorrhage
por: Lovisa Tobieson, et al.
Publicado: (2021)

Peptidome analysis of cerebrospinal fluid by LC-MALDI MS.
por: Mikko Hölttä, et al.
Publicado: (2012)

BACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous system.
por: Niklas Mattsson, et al.
Publicado: (2012)

Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression: a preliminary study
por: Kenji Hashimoto, et al.
Publicado: (2017)

The localization of amyloid precursor protein to ependymal cilia in vertebrates and its role in ciliogenesis and brain development in zebrafish
por: Jasmine Chebli, et al.
Publicado: (2021)

Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
por: Sebastian Palmqvist, et al.
Publicado: (2017)

Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia
por: Franc Llorens, et al.
Publicado: (2020)

Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy
por: Anna M. De Kort, et al.
Publicado: (2021)

Generation of amyloid-β is reduced by the interaction of calreticulin with amyloid precursor protein, presenilin and nicastrin.
por: Nina Stemmer, et al.
Publicado: (2013)

Cytotoxic aggregation and amyloid formation by the myostatin precursor protein.
por: Carlene S Starck, et al.
Publicado: (2010)

Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.
por: Magnus Gisslen, et al.
Publicado: (2021)

Amyloid precursor protein is trafficked and secreted via synaptic vesicles.
por: Teja W Groemer, et al.
Publicado: (2011)

A Luminex assay detects amyloid β oligomers in Alzheimer's disease cerebrospinal fluid.
por: Adrianna Z Herskovits, et al.
Publicado: (2013)

Low cerebrospinal fluid Amyloid-βeta 1–42 in patients with tuberculous meningitis
por: Giacomo Stroffolini, et al.
Publicado: (2021)

Overexpression of wild-type human amyloid precursor protein alters GABAergic transmission
por: Anna Kreis, et al.
Publicado: (2021)

HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration
por: Qingqing Chai, et al.
Publicado: (2017)

Formation and growth of oligomers: a Monte Carlo study of an amyloid tau fragment.
por: Da-Wei Li, et al.
Publicado: (2008)

Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study.
por: Sebastian Palmqvist, et al.
Publicado: (2012)

Microglia and amyloid precursor protein coordinate control of transient Candida cerebritis with memory deficits
por: Yifan Wu, et al.
Publicado: (2019)

Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis.
por: Petra Steinacker, et al.
Publicado: (2011)

Amyloid precursor protein is required for normal function of the rod and cone pathways in the mouse retina.
por: Tracy Ho, et al.
Publicado: (2012)

Influence of C-terminal truncation of murine Serum amyloid A on fibril structure
por: Matthies Rennegarbe, et al.
Publicado: (2017)

An intracellular threonine of amyloid-β precursor protein mediates synaptic plasticity deficits and memory loss.
por: Franco Lombino, et al.
Publicado: (2013)

Author Correction: HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration
por: Qingqing Chai, et al.
Publicado: (2018)

N-terminal prolactin-derived fragments, vasoinhibins, are proapoptoptic and antiproliferative in the anterior pituitary.
por: Jimena Ferraris, et al.
Publicado: (2011)

Truncating tau reveals different pathophysiological actions of oligomers in single neurons
por: Emily Hill, et al.
Publicado: (2021)

Under Conditions of Amyloid Formation Bovine Carbonic Anhydrase B Undergoes Fragmentation by Acid Hydrolysis
por: Victor Marchenkov, et al.
Publicado: (2021)

The amyloid precursor protein (APP) does not have a ferroxidase site in its E2 domain.
por: Kourosh Honarmand Ebrahimi, et al.
Publicado: (2013)

16S rRNA terminal restriction fragment length polymorphism for the characterization of the nasopharyngeal microbiota.
por: Silvio D Brugger, et al.
Publicado: (2012)

Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus.
por: Okko T Pyykkö, et al.
Publicado: (2014)

Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis
por: Niklas Mattsson, et al.
Publicado: (2016)

Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington’s disease
por: Zhen-Yi Andy Ou, et al.
Publicado: (2021)

Differential effects of interleukin-1&beta; and S100B on amyloid precursor protein in rat retinal neurons
por: Peter JB Anderson, et al.
Publicado: (2009)

Proteomic blood profiling in mild, severe and critical COVID-19 patients
por: Hamel Patel, et al.
Publicado: (2021)

Evidence of Neuroinflammation and Blood–Brain Barrier Disruption in Women with Preeclampsia and Eclampsia
por: Lina Bergman, et al.
Publicado: (2021)

Higher Plasma APOC-III Was Associated with a Slower Reduction of β-Amyloid Levels in Cerebrospinal Fluid Among Older Individuals Without Dementia
por: Zhang X
Publicado: (2020)

Enhanced oncolytic adenoviral production by downregulation of death-domain associated protein and overexpression of precursor terminal protein
por: Jihyun Lee, et al.
Publicado: (2021)

Preferential binding of fullerene and fullerenol with the N-terminal and middle regions of amyloid beta peptide: an in silico investigation
por: Pandya V, et al.
Publicado: (2018)

Multiscale Modeling of Amyloid Fibrils Formed by Aggregating Peptides Derived from the Amyloidogenic Fragment of the A-Chain of Insulin
por: Michał Koliński, et al.
Publicado: (2021)

Secreted human amyloid precursor protein binds semaphorin 3a and prevents semaphorin-induced growth cone collapse.
por: Margaret H Magdesian, et al.
Publicado: (2011)